| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $829.45M | $3.55M | $240.74M | $243.23M | $138.29M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $731.10M | $604.63M | $445.74M | $421.74M | $287.32M |
| R&D | $607.16M | $505.87M | $353.19M | $297.31M | $206.34M |
| SG&A | $123.94M | $98.76M | $92.55M | $124.43M | $80.98M |
| Operating Income | $98.35M | -$601.08M | -$205.00M | -$178.51M | -$149.04M |
| Interest Expense | – | – | $18.33M | $0.00 | $0.00 |
| Tax Expense | $21.42M | -$2.77M | $2.78M | $3.79M | $2.00K |
| Net Income | -$1.63M | -$599.49M | -$205.28M | -$176.06M | -$140.85M |
| EPS (basic) | -0.0100 | -5.0000 | -1.9200 | -1.6700 | -1.3600 |
| EPS (diluted) | -0.0100 | -5.0000 | -1.9200 | -1.6700 | -1.3600 |
| Shares (diluted) | $133.76M | $119.78M | $106.75M | $105.43M | $103.75M |